Kiora Pharmaceuticals Inc SEC filings KPHMW
Kiora Pharmaceuticals Inc has 926 filings in SEC EDGAR's recent list, going back to Aug 9, 2006. Its latest annual report, Form ARS, was filed on May 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (material agreement, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Oct 29, 2026 | Oct 23, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 8, 2026 | Sep 8, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Aug 19, 2026 | Aug 19, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2026 | Aug 7, 2026 |
| 10-Q | Quarterly report | Aug 7, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 18, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 11, 2026 | Jun 10, 2026 |
| 424B3 | Prospectus | May 28, 2026 | — |
| EFFECT | Filing | May 22, 2026 | — |
| CORRESP | Letter to the SEC | May 20, 2026 | — |
| UPLOAD | Letter from the SEC | May 20, 2026 | — |
| S-3 | Shelf registration | May 18, 2026 | — |
| 8-K |
Current report
Results of operations
|
May 8, 2026 | May 8, 2026 |
| 10-Q | Quarterly report | May 8, 2026 | Mar 31, 2026 |
| ARS | Annual report to shareholders | May 1, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Apr 30, 2026 | Apr 16, 2026 |
| D | Filing | Apr 21, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Apr 7, 2026 | Apr 3, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 2, 2026 | Apr 1, 2026 |
| S-8 | Employee stock plan registration | Mar 25, 2026 | — |
| 8-K |
Current report
Results of operations
|
Mar 25, 2026 | Mar 25, 2026 |
| 10-K | Annual report | Mar 25, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2025 | Nov 7, 2025 |
| 10-Q | Quarterly report | Nov 7, 2025 | Sep 30, 2025 |
| EFFECT | Filing | Sep 19, 2025 | — |
| CORRESP | Letter to the SEC | Sep 17, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 16, 2025 | — |
| S-3 | Shelf registration | Sep 15, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 13, 2025 | Aug 13, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2025 | Aug 8, 2025 |
| 10-Q | Quarterly report | Aug 8, 2025 | Jun 30, 2025 |
| UPLOAD | Letter from the SEC | Jul 1, 2025 | — |
| CORRESP | Letter to the SEC | Jun 20, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 10, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2025 | Jun 4, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 3, 2025 | May 30, 2025 |
| 8-K |
Current report
Results of operations
|
May 9, 2025 | May 9, 2025 |
| 10-Q | Quarterly report | May 9, 2025 | Mar 31, 2025 |
| DEF 14A | Proxy statement | Apr 30, 2025 | Apr 16, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 25, 2025 | Mar 25, 2025 |
| S-8 | Employee stock plan registration | Mar 25, 2025 | — |
| 10-K | Annual report | Mar 25, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Officer or director change
|
Jan 15, 2025 | Jan 10, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2024 | Nov 8, 2024 |
| 10-Q | Quarterly report | Nov 8, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 29, 2024 | Oct 29, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2024 | Aug 9, 2024 |
| 10-Q | Quarterly report | Aug 9, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Other events
|
Jul 30, 2024 | Jul 30, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Jul 1, 2024 | Jun 28, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Jun 7, 2024 | Jun 6, 2024 |
| 8-K |
Current report
Results of operations
|
May 10, 2024 | May 10, 2024 |
| 10-Q | Quarterly report | May 10, 2024 | Mar 31, 2024 |
| S-8 | Employee stock plan registration | May 10, 2024 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
May 3, 2024 | May 1, 2024 |
| EFFECT | Filing | Mar 28, 2024 | — |
| 424B3 | Prospectus | Mar 28, 2024 | — |
| CORRESP | Letter to the SEC | Mar 26, 2024 | — |
| DEF 14A | Proxy statement | Mar 25, 2024 | May 1, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 25, 2024 | Mar 25, 2024 |
| 10-K | Annual report | Mar 25, 2024 | Dec 31, 2023 |
| PRE 14A | Preliminary proxy statement | Mar 15, 2024 | May 1, 2024 |
| UPLOAD | Letter from the SEC | Mar 4, 2024 | — |
| S-3 | Shelf registration | Feb 28, 2024 | — |
| D | Filing | Feb 14, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 12, 2024 | Feb 12, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Feb 1, 2024 | Jan 31, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jan 31, 2024 | Jan 25, 2024 |
| 8-K |
Current report
Listing notice
|
Jan 16, 2024 | Jan 16, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K | Current report | Nov 6, 2023 | Nov 4, 2023 |
| S-8 | Employee stock plan registration | Oct 13, 2023 | — |
| 8-K |
Current report
Shareholder vote results
|
Sep 28, 2023 | Sep 27, 2023 |
| 8-K |
Current report
Officer or director change, Other events
|
Sep 21, 2023 | Sep 20, 2023 |
| DEFA14A | Additional proxy material | Sep 1, 2023 | — |
| 8-K |
Current report
Other events
|
Sep 1, 2023 | Aug 31, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2023 | Aug 8, 2023 |
| 10-Q | Quarterly report | Aug 8, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 1, 2023 | Aug 1, 2023 |
| DEF 14A | Proxy statement | Jul 21, 2023 | Aug 31, 2023 |
| 8-K |
Current report
Listing notice
|
Jul 20, 2023 | Jul 18, 2023 |
| PRE 14A | Preliminary proxy statement | Jul 11, 2023 | Aug 31, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2023 | Jun 21, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 15, 2023 | Jun 12, 2023 |
| 8-K |
Current report
Material agreement, Bylaw or fiscal year change, Other events
|
Jun 6, 2023 | Jun 2, 2023 |
| 424B1 | Filing | Jun 2, 2023 | — |
| EFFECT | Filing | Jun 1, 2023 | — |
| S-1/A | Amended registration statement | Jun 1, 2023 | — |
| CORRESP | Letter to the SEC | May 31, 2023 | — |
| CORRESP | Letter to the SEC | May 31, 2023 | — |
| CORRESP | Letter to the SEC | May 24, 2023 | — |
| CORRESP | Letter to the SEC | May 24, 2023 | — |
| CORRESP | Letter to the SEC | May 23, 2023 | — |
| FWP | Free writing prospectus | May 15, 2023 | — |
| S-1/A | Amended registration statement | May 12, 2023 | — |
| UPLOAD | Letter from the SEC | May 9, 2023 | — |
| 8-K |
Current report
Results of operations
|
May 9, 2023 | May 9, 2023 |
| 10-Q | Quarterly report | May 9, 2023 | Mar 31, 2023 |
| S-1 | Registration statement | May 5, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | Jun 21, 2023 |
| 8-K |
Current report
Other events
|
Apr 27, 2023 | Apr 27, 2023 |
| 8-K |
Current report
Auditor change
|
Mar 30, 2023 | Mar 24, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 23, 2023 | Mar 23, 2023 |
| 10-K | Annual report | Mar 23, 2023 | Dec 31, 2022 |
| D | Filing | Feb 17, 2023 | — |
| D | Filing | Feb 17, 2023 | — |
| EFFECT | Filing | Feb 13, 2023 | — |
| 424B3 | Prospectus | Feb 13, 2023 | — |
| CORRESP | Letter to the SEC | Feb 9, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 9, 2023 | — |
| 8-K |
Current report
Other events
|
Feb 7, 2023 | Feb 7, 2023 |
| S-1 | Registration statement | Feb 3, 2023 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Feb 3, 2023 | Feb 3, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Other events
|
Jan 3, 2023 | Jan 1, 2023 |
| EFFECT | Filing | Dec 28, 2022 | — |
| 424B3 | Prospectus | Dec 28, 2022 | — |
| CORRESP | Letter to the SEC | Dec 23, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 23, 2022 | — |
| S-1 | Registration statement | Dec 22, 2022 | — |
| 424B3 | Prospectus | Nov 21, 2022 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Other events
|
Nov 21, 2022 | Nov 17, 2022 |
| 10-Q | Quarterly report | Nov 9, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Other events
|
Oct 13, 2022 | Oct 13, 2022 |
| S-8 | Employee stock plan registration | Oct 5, 2022 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Sep 26, 2022 | Sep 23, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Sep 23, 2022 | Sep 23, 2022 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Other events
|
Sep 16, 2022 | Sep 13, 2022 |
| 8-K |
Current report
Listing notice
|
Aug 25, 2022 | Aug 23, 2022 |
| DEF 14A | Proxy statement | Aug 15, 2022 | Sep 23, 2022 |
| 10-Q | Quarterly report | Aug 12, 2022 | Jun 30, 2022 |
| DEF 14A | Proxy statement | Aug 8, 2022 | Sep 15, 2022 |
| PRE 14A | Preliminary proxy statement | Aug 5, 2022 | Sep 23, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Aug 4, 2022 | Aug 1, 2022 |
| PRE 14A | Preliminary proxy statement | Jul 27, 2022 | Sep 15, 2022 |
| 8-K |
Current report
Material agreement, Bylaw or fiscal year change, Other events
|
Jul 26, 2022 | Jul 22, 2022 |
| 424B1 | Filing | Jul 25, 2022 | — |
| EFFECT | Filing | Jul 21, 2022 | — |
| CORRESP | Letter to the SEC | Jul 21, 2022 | — |
| S-1/A | Amended registration statement | Jul 21, 2022 | — |
| CORRESP | Letter to the SEC | Jul 19, 2022 | — |
| S-1/A | Amended registration statement | Jul 19, 2022 | — |
| FWP | Free writing prospectus | Jul 14, 2022 | — |
| S-1/A | Amended registration statement | Jul 13, 2022 | — |
| 10-Q | Quarterly report | Jul 8, 2022 | Mar 31, 2022 |
| 10-K/A | Amended annual report | Jul 7, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Officer or director change
|
Jun 21, 2022 | Jun 16, 2022 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
May 31, 2022 | May 25, 2022 |
| 8-K |
Current report
Restatement
|
May 23, 2022 | May 20, 2022 |
| NT 10-Q | Filing | May 17, 2022 | Mar 31, 2022 |
| UPLOAD | Letter from the SEC | May 9, 2022 | — |
| S-1 | Registration statement | May 3, 2022 | — |
| S-8 | Employee stock plan registration | May 3, 2022 | — |
| 8-K |
Current report
Officer or director change
|
Apr 26, 2022 | Apr 21, 2022 |
| 10-K | Annual report | Apr 15, 2022 | Dec 31, 2021 |
| NT 10-K | Form nt 10-k | Mar 31, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Officer or director change
|
Mar 23, 2022 | Mar 18, 2022 |
| 8-K |
Current report
Listing notice, Officer or director change
|
Feb 28, 2022 | Feb 23, 2022 |
| 8-K |
Current report
Officer or director change
|
Feb 14, 2022 | Feb 9, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Feb 1, 2022 | Jan 31, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 11, 2022 | Jan 10, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 15, 2021 | Dec 13, 2021 |
| 8-K |
Current report
Other events
|
Dec 14, 2021 | Dec 14, 2021 |
| 10-Q | Quarterly report | Nov 15, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Nov 8, 2021 | Nov 5, 2021 |
| D | Filing | Nov 4, 2021 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Regulation FD disclosure
|
Oct 26, 2021 | Oct 21, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 14, 2021 | Sep 14, 2021 |
| 8-K |
Current report
Officer or director change
|
Aug 26, 2021 | Aug 20, 2021 |
| D | Filing | Aug 23, 2021 | — |
| 10-Q | Quarterly report | Aug 12, 2021 | Jun 30, 2021 |
| 424B5 | Prospectus supplement | Aug 11, 2021 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Aug 10, 2021 | Aug 9, 2021 |
| 8-K |
Current report
Officer or director change
|
Aug 4, 2021 | Aug 3, 2021 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 26, 2021 | Jul 22, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 25, 2021 | Jun 24, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
May 27, 2021 | May 27, 2021 |
| 10-Q | Quarterly report | May 12, 2021 | Mar 31, 2021 |
| EFFECT | Filing | Apr 30, 2021 | — |
| 424B3 | Prospectus | Apr 30, 2021 | — |
| DEFA14A | Additional proxy material | Apr 30, 2021 | — |
| DEF 14A | Proxy statement | Apr 30, 2021 | Jun 24, 2021 |
| CORRESP | Letter to the SEC | Apr 28, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 21, 2021 | — |
| PRE 14A | Preliminary proxy statement | Apr 20, 2021 | Apr 20, 2021 |
| S-3 | Shelf registration | Apr 16, 2021 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 1, 2021 | Mar 30, 2021 |
| 10-K | Annual report | Mar 25, 2021 | Dec 31, 2020 |
| 8-K/A | Amended current report | Mar 5, 2021 | Dec 18, 2020 |
| 8-K |
Current report
Officer or director change, Other events
|
Feb 1, 2021 | Jan 29, 2021 |
| D | Filing | Jan 21, 2021 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jan 6, 2021 | Jan 5, 2021 |
| D | Filing | Jan 4, 2021 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Bylaw or fiscal year change, Other events
|
Dec 21, 2020 | Dec 18, 2020 |
| 10-Q | Quarterly report | Nov 9, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 14, 2020 | Sep 14, 2020 |
| S-8 | Employee stock plan registration | Aug 6, 2020 | — |
| 10-Q | Quarterly report | Aug 6, 2020 | Jun 30, 2020 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- KPRX (Nasdaq), KPHMW (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Encinitas, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1372514
- Former names
- EYEGATE PHARMACEUTICALS INC (until Nov 4, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.